Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about OKYO Pharma
Recent news which mentions OKYO Pharma
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
June 01, 2023
Tickers
ALPMF
ISEE
OKYO
VTRS
Tags
XNAS:OKYO
OKYO Pharma
From
TheNewswire.com - RSS (Media)
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
May 30, 2023
Tickers
ALPMF
ISEE
OKYO
VTRS
Tags
VTRS
General
Health Care
From
Benzinga
Phase 2 Trials Begin For Promising New Dry Eye Disease Treatment From OKYO Pharma
May 12, 2023
Tickers
OKYO
Tags
General
Interview
OKYO Pharma
From
Benzinga
OKYO Pharma Reports First Patient Visit For Phase 2 Trial Of OK-101, To Fulfill One Of The Two Phase 3 Studies Required For FDA Approval If Successful
May 03, 2023
Tickers
OKYO
Tags
General
OKYO
Biotech
From
Benzinga
OKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye Disease
April 26, 2023
Tickers
OKYO
Tags
Market News
OKYO Pharma
OKYO
From
Benzinga
OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay
April 18, 2023
Tickers
ALDX
OCUL
OKYO
TARS
Tags
OKYO
ALDX
News
From
Benzinga
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
March 28, 2023
Tickers
ALDX
OCUL
OKYO
TARS
Tags
XNAS:OKYO
OKYO Pharma
From
TheNewswire.com - RSS (Media)
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
March 28, 2023
Tickers
ALDX
OCUL
OKYO
TARS
Tags
TARS
ALDX
News
From
Benzinga
OKYO Pharma's Trial Treating Subjects With DED Gets Listed On ClinicalTrials.gov
March 17, 2023
Tickers
OKYO
Tags
OKYO
Biotech
News
From
Benzinga
OKYO Pharma CEO Gary Jacob Discusses The Company's Future Plans
March 10, 2023
Tags
Interview
Market News
Biotech
From
Benzinga
OKYO Pharma's Drug OK-101 Clears Customs in the US; To Be Used In Phase 2, First-In-Human, Clinical Trial For Patients With Dry Eye Disease
March 01, 2023
Tickers
OKYO
Tags
Market News
Penny Stocks
Benzinga
From
Benzinga
Dry Eye Disease Impacts 49 Million Americans And Disproportionately Affects Women, But Current Treatments Aren't Fully Effective – OKYO Pharma's Drug Candidate Could Be The Solution
February 23, 2023
Tickers
ALDX
OKYO
TARS
Tags
OKYO Pharma
XNAS:OKYO
From
TheNewswire.com - RSS (Media)
Bio-Pharma Company OKYO Pharma Tackles A Common Eye Disease For Which The Current Treatments Aren't Effective Enough
February 23, 2023
Tickers
ALDX
OKYO
TARS
Tags
ALDX
OKYO
Partner Content
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.